Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hurley (Dublin 3, Ireland). Using induced pluripotent stem cells to study the type II pneumocyte. Virtual Congress 2020 – Human ex vivo models of interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Effect of hypoxia on gene regulation and differentiation in alveolar epithelial type II cells Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001 Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 Oral presentation: Identification of a novel subpopulation of virus-resistant progenitor epithelial type II cells in mice Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Alveolar epithelial type II cells from embryonic stem cells: knights in shining armour? Source: Eur Respir J 2012; 39: 240-241 Year: 2012 Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers Source: Eur Respir J, 56 (4) 2000853; 10.1183/13993003.00853-2020 Year: 2020 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 microRNA profiling of murine alveolar epithelial type II cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Deriving type II alveolar cells from pluripotent stem cells to produce a novel model of alpha-1 antitrypsin deficiency pathogenesis Source: International Congress 2016 – Mechanisms of disease Year: 2016 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC) Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Wnt11 inhibits epithelial-mesenchymal transition induced by TGFb1 in human type II alveolar epithelial cells Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012